FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 48 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $270,000 | -20.4% | 112,536 | +24.3% | 0.00% | – |
| Q1 2019 | $339,000 | +11.9% | 90,509 | +49.6% | 0.00% | – |
| Q2 2018 | $303,000 | +30200.0% | 60,488 | +27774.7% | 0.00% | – |
| Q3 2017 | $1,000 | -98.2% | 217 | -98.2% | 0.00% | – |
| Q2 2017 | $55,000 | +685.7% | 11,806 | +1832.2% | 0.00% | – |
| Q4 2016 | $7,000 | -99.4% | 611 | -99.7% | 0.00% | – |
| Q1 2016 | $1,232,000 | -26.3% | 188,925 | -8.3% | 0.00% | – |
| Q4 2015 | $1,671,000 | -67.5% | 206,000 | -71.9% | 0.00% | -100.0% |
| Q4 2014 | $5,138,000 | +57.1% | 732,890 | +22.1% | 0.00% | 0.0% |
| Q3 2014 | $3,270,000 | – | 600,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 4,781,708 | $24,530,000,000 | 3.64% |
| Opaleye Management Inc. | 950,000 | $4,873,000 | 1.39% |
| DSC Advisors, L.P. | 1,187,604 | $6,092,000 | 1.28% |
| DAFNA Capital Management LLC | 335,500 | $1,721,000 | 0.84% |
| Vivo Capital, LLC | 855,000 | $4,386,000 | 0.62% |
| Stonepine Capital Management, LLC | 129,756 | $666,000 | 0.36% |
| Eversept Partners, LP | 107,500 | $551,475 | 0.26% |
| Tekla Capital Management LLC | 930,398 | $4,773,000 | 0.19% |
| Perceptive Advisors | 1,117,324 | $5,732,000 | 0.16% |
| Crestline Management, LP | 217,670 | $1,117,000 | 0.14% |